The kissing question and other ICAAC highlights.
Grodeck
B
B
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000635:transmission*; D000328:Adult; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents / Q000627:therapeutic use*; D001727:Bisexuality; D018791:CD4 Lymphocyte Count / Q000187:drug effects*; D002648:Child; D017726:Cytomegalovirus Retinitis; D016049:Didanosine / Q000627:therapeutic use; D018450:Disease Progression; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006235:Hand Disinfection; D019288:Herpesvirus 8, Human; D018451:Homosexuality, Male; D006801:Humans; D019469:Indinavir / Q000009:adverse effects / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008508:Medication Errors; D016881:Microsporidiosis; D015270:Mycobacterium avium-intracellulare Infection; D009316:National Institutes of Health (U.S.); D010595:Pharmacists; D011020:Pneumonia, Pneumocystis; D012463:Saliva / Q000821:virology*; D012514:Sarcoma, Kaposi; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*; D014481:United States; D019562:Viral Load; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D007376:Interleukin-2; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016047:Zalcitabine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015725:Fluconazole; D016049:Didanosine